Krishna Institute of Medical Sciences · NSE: KIMS · BSE: 543308
Q4 FY25 results · Jan–Mar 2025
Krishna Institute of Medical Sciences reported revenue from operations of ₹796.90 crore (up 25.7% from Q4 FY24) and net profit of ₹106.10 crore (up 48.4% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 796.90 | 633.80 | +25.7% | 772.40 | +3.2% |
| Other income | 4.50 | 3.81 | +18.2% | 17.80 | −74.7% |
| Total income | 801.40 | 637.60 | +25.7% | 790.20 | +1.4% |
| Profit before tax | 134.00 | 100.12 | +33.8% | 134.60 | −0.4% |
| Net profit for the period | 106.10 | 71.49 | +48.4% | 92.50 | +14.7% |
| Attributable to shareholders of the company | 101.80 | 65.47 | +55.5% | — | — |
| EPS, basic (₹) | 2.54 | 8.18 | not comparable | 2.22 | +14.4% |
| Net margin (%) | 13.3 | 11.3 | 12.0 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 345.90 | 304.85 | +13.5% | 347.50 | −0.5% |
| Other income | 24.20 | 3.90 | +520.8% | 20.60 | +17.5% |
| Total income | 370.10 | 308.74 | +19.9% | 368.10 | +0.5% |
| Profit before tax | 120.60 | 67.47 | +78.8% | 101.90 | +18.4% |
| Net profit for the period | 93.60 | 48.19 | +94.2% | 76.50 | +22.4% |
| EPS, basic (₹) | 2.34 | 6.02 | not comparable | 1.91 | +22.5% |
| Net margin (%) | 27.1 | 15.8 | 22.0 |
Consolidated
- Filed with BSE
- 12 May 2025, 23:46 IST
- Board meeting
- 12 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 May 2025, 23:46 IST
- Board meeting
- 12 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE